> top > docs > PubMed:28777492 > annotations

PubMed:28777492 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-114 Sentence denotes Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma.
T2 115-203 Sentence denotes Most hepatocellular carcinomas (HCCs) develop as a result of chronic liver inflammation.
T3 204-313 Sentence denotes We have shown that the oncoprotein gankyrin is critical for inflammation-induced tumourigenesis in the colon.
T4 314-414 Sentence denotes Although the in vitro function of gankyrin is well known, its role in vivo remains to be elucidated.
T5 415-668 Sentence denotes We investigated the effect of gankyrin in tumour microenvironment of mice with liver parenchymal cell-specific gankyrin ablation (Alb-Cre;gankyrin(f/f) ) and gankyrin deletion both in liver parenchymal and non-parenchymal cells (Mx1-Cre;gankyrin(f/f) ).
T6 669-721 Sentence denotes Gankyrin upregulates VEGF expression in tumor cells.
T7 722-968 Sentence denotes Gankyrin binds to Src homology 2 domain-containing protein tyrosine phosphatase-1 (SHP-1), mainly expressed in liver non-parenchymal cells, resulting in phosphorylation and activation of signal transducer and activator of transcription 3 (STAT3).
T8 969-1238 Sentence denotes Gankyrin deficiency in non-parenchymal cells, but not in parenchymal cells, reduced STAT3 activity, interleukin (IL)-6 production, and cancer stem cell marker (Bmi1 and epithelial cell adhesion molecule [EpCAM]) expression, leading to attenuated tumourigenic potential.
T9 1239-1308 Sentence denotes Chronic inflammation enhances gankyrin expression in the human liver.
T10 1309-1467 Sentence denotes Gankyrin expression in the tumour microenvironment is negatively correlated with progression-free survival in patients undergoing sorafenib treatment for HCC.
T11 1468-1651 Sentence denotes Thus, gankyrin appears to play a critical oncogenic function in tumour microenvironment and may be a potential target for developing therapeutic and preventive strategies against HCC.
T12 1652-1691 Sentence denotes This article is protected by copyright.
T13 1692-1712 Sentence denotes All rights reserved.
T1 0-114 Sentence denotes Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma.
T2 115-203 Sentence denotes Most hepatocellular carcinomas (HCCs) develop as a result of chronic liver inflammation.
T3 204-313 Sentence denotes We have shown that the oncoprotein gankyrin is critical for inflammation-induced tumourigenesis in the colon.
T4 314-414 Sentence denotes Although the in vitro function of gankyrin is well known, its role in vivo remains to be elucidated.
T5 415-668 Sentence denotes We investigated the effect of gankyrin in tumour microenvironment of mice with liver parenchymal cell-specific gankyrin ablation (Alb-Cre;gankyrin(f/f) ) and gankyrin deletion both in liver parenchymal and non-parenchymal cells (Mx1-Cre;gankyrin(f/f) ).
T6 669-721 Sentence denotes Gankyrin upregulates VEGF expression in tumor cells.
T7 722-968 Sentence denotes Gankyrin binds to Src homology 2 domain-containing protein tyrosine phosphatase-1 (SHP-1), mainly expressed in liver non-parenchymal cells, resulting in phosphorylation and activation of signal transducer and activator of transcription 3 (STAT3).
T8 969-1238 Sentence denotes Gankyrin deficiency in non-parenchymal cells, but not in parenchymal cells, reduced STAT3 activity, interleukin (IL)-6 production, and cancer stem cell marker (Bmi1 and epithelial cell adhesion molecule [EpCAM]) expression, leading to attenuated tumourigenic potential.
T9 1239-1308 Sentence denotes Chronic inflammation enhances gankyrin expression in the human liver.
T10 1309-1467 Sentence denotes Gankyrin expression in the tumour microenvironment is negatively correlated with progression-free survival in patients undergoing sorafenib treatment for HCC.
T11 1468-1651 Sentence denotes Thus, gankyrin appears to play a critical oncogenic function in tumour microenvironment and may be a potential target for developing therapeutic and preventive strategies against HCC.
T12 1652-1691 Sentence denotes This article is protected by copyright.
T13 1692-1712 Sentence denotes All rights reserved.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 484-488 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T3 1296-1301 OrganismTaxon denotes human NCBItxid:9606

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-114 Sentence denotes Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma.
T2 115-203 Sentence denotes Most hepatocellular carcinomas (HCCs) develop as a result of chronic liver inflammation.
T3 204-313 Sentence denotes We have shown that the oncoprotein gankyrin is critical for inflammation-induced tumourigenesis in the colon.
T4 314-414 Sentence denotes Although the in vitro function of gankyrin is well known, its role in vivo remains to be elucidated.
T5 415-668 Sentence denotes We investigated the effect of gankyrin in tumour microenvironment of mice with liver parenchymal cell-specific gankyrin ablation (Alb-Cre;gankyrin(f/f) ) and gankyrin deletion both in liver parenchymal and non-parenchymal cells (Mx1-Cre;gankyrin(f/f) ).
T6 669-721 Sentence denotes Gankyrin upregulates VEGF expression in tumor cells.
T7 722-968 Sentence denotes Gankyrin binds to Src homology 2 domain-containing protein tyrosine phosphatase-1 (SHP-1), mainly expressed in liver non-parenchymal cells, resulting in phosphorylation and activation of signal transducer and activator of transcription 3 (STAT3).
T8 969-1238 Sentence denotes Gankyrin deficiency in non-parenchymal cells, but not in parenchymal cells, reduced STAT3 activity, interleukin (IL)-6 production, and cancer stem cell marker (Bmi1 and epithelial cell adhesion molecule [EpCAM]) expression, leading to attenuated tumourigenic potential.
T9 1239-1308 Sentence denotes Chronic inflammation enhances gankyrin expression in the human liver.
T10 1309-1467 Sentence denotes Gankyrin expression in the tumour microenvironment is negatively correlated with progression-free survival in patients undergoing sorafenib treatment for HCC.
T11 1468-1651 Sentence denotes Thus, gankyrin appears to play a critical oncogenic function in tumour microenvironment and may be a potential target for developing therapeutic and preventive strategies against HCC.
T12 1652-1691 Sentence denotes This article is protected by copyright.
T13 1692-1712 Sentence denotes All rights reserved.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
13250 0-8 GeneOrGeneProduct denotes Gankyrin NCBIGene:53380
13251 17-22 GeneOrGeneProduct denotes STAT3 NCBIGene:20848
13252 37-43 DiseaseOrPhenotypicFeature denotes tumour MESH:D009369
13253 65-74 ChemicalEntity denotes sorafenib MESH:D000077157
13254 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma MESH:D006528
13255 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas MESH:D006528
13256 147-150 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
13257 176-202 DiseaseOrPhenotypicFeature denotes chronic liver inflammation MESH:D007249
13258 227-238 GeneOrGeneProduct denotes oncoprotein NCBIGene:53380
13259 239-247 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13260 264-276 DiseaseOrPhenotypicFeature denotes inflammation MESH:D007249
13261 285-299 DiseaseOrPhenotypicFeature denotes tumourigenesis MESH:D009369
13262 348-356 GeneOrGeneProduct denotes gankyrin NCBIGene:5716
13263 445-453 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13264 458-463 DiseaseOrPhenotypicFeature denotes umour MESH:D009369
13265 484-488 OrganismTaxon denotes mice NCBITaxon:10090
13266 526-534 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13267 545-548 GeneOrGeneProduct denotes Alb NCBIGene:11657
13268 553-561 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13269 573-581 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13270 644-647 GeneOrGeneProduct denotes Mx1 NCBIGene:17857
13271 652-660 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13272 669-677 GeneOrGeneProduct denotes Gankyrin NCBIGene:5716
13273 690-694 GeneOrGeneProduct denotes VEGF NCBIGene:22339
13274 709-714 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
13275 722-730 GeneOrGeneProduct denotes Gankyrin NCBIGene:53380
13276 740-803 GeneOrGeneProduct denotes Src homology 2 domain-containing protein tyrosine phosphatase-1 NCBIGene:15170
13277 805-810 GeneOrGeneProduct denotes SHP-1 NCBIGene:15170
13278 909-959 GeneOrGeneProduct denotes signal transducer and activator of transcription 3 NCBIGene:20848
13279 961-966 GeneOrGeneProduct denotes STAT3 NCBIGene:20848
13280 969-977 GeneOrGeneProduct denotes Gankyrin NCBIGene:53380
13281 1053-1058 GeneOrGeneProduct denotes STAT3 NCBIGene:20848
13282 1069-1087 GeneOrGeneProduct denotes interleukin (IL)-6 NCBIGene:16193
13283 1104-1110 DiseaseOrPhenotypicFeature denotes cancer MESH:D009369
13284 1129-1133 GeneOrGeneProduct denotes Bmi1 NCBIGene:12151
13285 1138-1171 GeneOrGeneProduct denotes epithelial cell adhesion molecule NCBIGene:17075
13286 1173-1178 GeneOrGeneProduct denotes EpCAM NCBIGene:17075
13287 1215-1227 DiseaseOrPhenotypicFeature denotes tumourigenic MESH:D009369
13288 1239-1259 DiseaseOrPhenotypicFeature denotes Chronic inflammation MESH:D007249
13289 1269-1277 GeneOrGeneProduct denotes gankyrin NCBIGene:5716
13290 1296-1301 OrganismTaxon denotes human NCBITaxon:9606
13291 1309-1317 GeneOrGeneProduct denotes Gankyrin NCBIGene:5716
13292 1336-1342 DiseaseOrPhenotypicFeature denotes tumour MESH:D009369
13293 1419-1427 OrganismTaxon denotes patients NCBITaxon:9606
13294 1439-1448 ChemicalEntity denotes sorafenib MESH:D000077157
13295 1463-1466 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528
13296 1474-1482 GeneOrGeneProduct denotes gankyrin NCBIGene:53380
13297 1532-1538 DiseaseOrPhenotypicFeature denotes tumour MESH:D009369
13298 1647-1650 DiseaseOrPhenotypicFeature denotes HCC MESH:D006528

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma 0007256
T2 104-113 DiseaseOrPhenotypicFeature denotes carcinoma 0004993
T3 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas 0007256
T4 1104-1110 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 0-8 GeneOrGeneProduct denotes Gankyrin
T2 9-16 GeneOrGeneProduct denotes induces
T3 17-22 GeneOrGeneProduct denotes STAT3
T4 23-33 GeneOrGeneProduct denotes activation
T5 147-151 GeneOrGeneProduct denotes HCCs
T6 184-189 GeneOrGeneProduct denotes liver
T7 239-247 GeneOrGeneProduct denotes gankyrin
T8 277-284 GeneOrGeneProduct denotes induced
T9 348-356 GeneOrGeneProduct denotes gankyrin
T10 445-453 GeneOrGeneProduct denotes gankyrin
T11 484-488 GeneOrGeneProduct denotes mice
T12 494-499 GeneOrGeneProduct denotes liver
T13 512-516 GeneOrGeneProduct denotes cell
T14 526-534 GeneOrGeneProduct denotes gankyrin
T15 545-552 GeneOrGeneProduct denotes Alb-Cre
T16 553-561 GeneOrGeneProduct denotes gankyrin
T17 573-581 GeneOrGeneProduct denotes gankyrin
T18 599-604 GeneOrGeneProduct denotes liver
T19 637-642 GeneOrGeneProduct denotes cells
T20 644-647 GeneOrGeneProduct denotes Mx1
T21 652-660 GeneOrGeneProduct denotes gankyrin
T22 669-677 GeneOrGeneProduct denotes Gankyrin
T23 690-694 GeneOrGeneProduct denotes VEGF
T24 709-714 GeneOrGeneProduct denotes tumor
T25 715-720 GeneOrGeneProduct denotes cells
T26 722-730 GeneOrGeneProduct denotes Gankyrin
T27 731-736 GeneOrGeneProduct denotes binds
T28 744-752 GeneOrGeneProduct denotes homology
T29 755-780 GeneOrGeneProduct denotes domain-containing protein
T30 781-801 GeneOrGeneProduct denotes tyrosine phosphatase
T31 805-810 GeneOrGeneProduct denotes SHP-1
T32 813-819 GeneOrGeneProduct denotes mainly
T33 833-838 GeneOrGeneProduct denotes liver
T34 855-860 GeneOrGeneProduct denotes cells
T35 895-905 GeneOrGeneProduct denotes activation
T36 909-957 GeneOrGeneProduct denotes signal transducer and activator of transcription
T37 961-966 GeneOrGeneProduct denotes STAT3
T38 969-977 GeneOrGeneProduct denotes Gankyrin
T39 1008-1013 GeneOrGeneProduct denotes cells
T40 1038-1043 GeneOrGeneProduct denotes cells
T41 1045-1052 GeneOrGeneProduct denotes reduced
T42 1053-1058 GeneOrGeneProduct denotes STAT3
T43 1059-1067 GeneOrGeneProduct denotes activity
T44 1081-1087 GeneOrGeneProduct denotes (IL)-6
T45 1088-1098 GeneOrGeneProduct denotes production
T46 1116-1120 GeneOrGeneProduct denotes cell
T47 1129-1133 GeneOrGeneProduct denotes Bmi1
T48 1138-1171 GeneOrGeneProduct denotes epithelial cell adhesion molecule
T49 1173-1178 GeneOrGeneProduct denotes EpCAM
T50 1204-1214 GeneOrGeneProduct denotes attenuated
T51 1269-1277 GeneOrGeneProduct denotes gankyrin
T52 1302-1307 GeneOrGeneProduct denotes liver
T53 1309-1317 GeneOrGeneProduct denotes Gankyrin
T54 1474-1482 GeneOrGeneProduct denotes gankyrin
T55 1510-1519 GeneOrGeneProduct denotes oncogenic
T56 1560-1568 GeneOrGeneProduct denotes may be a
T57 1692-1695 GeneOrGeneProduct denotes All
T58 1696-1702 GeneOrGeneProduct denotes rights

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 0-8 GeneOrGeneProduct denotes Gankyrin
T2 17-22 GeneOrGeneProduct denotes STAT3
T3 184-189 GeneOrGeneProduct denotes liver
T4 239-247 GeneOrGeneProduct denotes gankyrin
T5 348-356 GeneOrGeneProduct denotes gankyrin
T6 445-453 GeneOrGeneProduct denotes gankyrin
T7 494-499 GeneOrGeneProduct denotes liver
T8 512-516 GeneOrGeneProduct denotes cell
T9 526-534 GeneOrGeneProduct denotes gankyrin
T10 545-552 GeneOrGeneProduct denotes Alb-Cre
T11 553-561 GeneOrGeneProduct denotes gankyrin
T12 573-581 GeneOrGeneProduct denotes gankyrin
T13 599-604 GeneOrGeneProduct denotes liver
T14 644-647 GeneOrGeneProduct denotes Mx1
T15 652-660 GeneOrGeneProduct denotes gankyrin
T16 669-677 GeneOrGeneProduct denotes Gankyrin
T17 690-694 GeneOrGeneProduct denotes VEGF
T18 722-730 GeneOrGeneProduct denotes Gankyrin
T19 755-780 GeneOrGeneProduct denotes domain-containing protein
T20 781-801 GeneOrGeneProduct denotes tyrosine phosphatase
T21 805-810 GeneOrGeneProduct denotes SHP-1
T22 833-838 GeneOrGeneProduct denotes liver
T23 909-957 GeneOrGeneProduct denotes signal transducer and activator of transcription
T24 961-966 GeneOrGeneProduct denotes STAT3
T25 969-977 GeneOrGeneProduct denotes Gankyrin
T26 1045-1052 GeneOrGeneProduct denotes reduced
T27 1053-1058 GeneOrGeneProduct denotes STAT3
T28 1116-1120 GeneOrGeneProduct denotes cell
T29 1129-1133 GeneOrGeneProduct denotes Bmi1
T30 1138-1171 GeneOrGeneProduct denotes epithelial cell adhesion molecule
T31 1173-1178 GeneOrGeneProduct denotes EpCAM
T32 1204-1214 GeneOrGeneProduct denotes attenuated
T33 1269-1277 GeneOrGeneProduct denotes gankyrin
T34 1302-1307 GeneOrGeneProduct denotes liver
T35 1309-1317 GeneOrGeneProduct denotes Gankyrin
T36 1474-1482 GeneOrGeneProduct denotes gankyrin

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 37-43 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T2 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T3 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T4 147-151 DiseaseOrPhenotypicFeature denotes HCCs D006528
T5 190-202 DiseaseOrPhenotypicFeature denotes inflammation D007249
T6 264-276 DiseaseOrPhenotypicFeature denotes inflammation D007249
T7 457-463 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T8 709-714 DiseaseOrPhenotypicFeature denotes tumor D009369
T9 1104-1110 DiseaseOrPhenotypicFeature denotes cancer D009369
T10 1247-1259 DiseaseOrPhenotypicFeature denotes inflammation D007249
T11 1336-1342 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T12 1463-1466 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T13 1532-1538 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T14 1647-1650 DiseaseOrPhenotypicFeature denotes HCC DISEASE

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 0-8 GeneOrGeneProduct denotes Gankyrin
T2 17-22 GeneOrGeneProduct denotes STAT3
T3 239-247 GeneOrGeneProduct denotes gankyrin
T4 348-356 GeneOrGeneProduct denotes gankyrin
T5 445-453 GeneOrGeneProduct denotes gankyrin
T6 526-534 GeneOrGeneProduct denotes gankyrin
T7 545-552 GeneOrGeneProduct denotes Alb-Cre
T8 553-561 GeneOrGeneProduct denotes gankyrin
T9 573-581 GeneOrGeneProduct denotes gankyrin
T10 644-647 GeneOrGeneProduct denotes Mx1
T11 652-660 GeneOrGeneProduct denotes gankyrin
T12 669-677 GeneOrGeneProduct denotes Gankyrin
T13 690-694 GeneOrGeneProduct denotes VEGF
T14 722-730 GeneOrGeneProduct denotes Gankyrin
T15 755-780 GeneOrGeneProduct denotes domain-containing protein
T16 781-801 GeneOrGeneProduct denotes tyrosine phosphatase
T17 805-810 GeneOrGeneProduct denotes SHP-1
T18 909-957 GeneOrGeneProduct denotes signal transducer and activator of transcription
T19 961-966 GeneOrGeneProduct denotes STAT3
T20 969-977 GeneOrGeneProduct denotes Gankyrin
T21 1053-1058 GeneOrGeneProduct denotes STAT3
T22 1129-1133 GeneOrGeneProduct denotes Bmi1
T23 1138-1171 GeneOrGeneProduct denotes epithelial cell adhesion molecule
T24 1173-1178 GeneOrGeneProduct denotes EpCAM
T25 1269-1277 GeneOrGeneProduct denotes gankyrin
T26 1309-1317 GeneOrGeneProduct denotes Gankyrin
T27 1474-1482 GeneOrGeneProduct denotes gankyrin

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma 0007256
T2 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas 0007256
T3 147-151 DiseaseOrPhenotypicFeature denotes HCCs 0007256
T4 184-202 DiseaseOrPhenotypicFeature denotes liver inflammation 0002251
T5 709-714 DiseaseOrPhenotypicFeature denotes tumor 0005070
T6 1463-1466 DiseaseOrPhenotypicFeature denotes HCC 0007256
T7 1647-1650 DiseaseOrPhenotypicFeature denotes HCC 0007256

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 37-43 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T2 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T3 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T4 147-151 DiseaseOrPhenotypicFeature denotes HCCs D006528
T5 190-202 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T7 264-276 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T9 285-299 DiseaseOrPhenotypicFeature denotes tumourigenesis DISEASE
T10 457-463 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T11 709-714 DiseaseOrPhenotypicFeature denotes tumor D009369
T12 1104-1110 DiseaseOrPhenotypicFeature denotes cancer D009369
T13 1215-1227 DiseaseOrPhenotypicFeature denotes tumourigenic DISEASE
T14 1247-1259 DiseaseOrPhenotypicFeature denotes inflammation DISEASE|D007249
T16 1336-1342 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T17 1463-1466 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T18 1532-1538 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T19 1647-1650 DiseaseOrPhenotypicFeature denotes HCC DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 37-43 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T2 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T3 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T4 147-151 DiseaseOrPhenotypicFeature denotes HCCs D006528
T5 190-202 DiseaseOrPhenotypicFeature denotes inflammation D007249
T6 264-276 DiseaseOrPhenotypicFeature denotes inflammation D007249
T7 285-299 DiseaseOrPhenotypicFeature denotes tumourigenesis DISEASE
T8 457-463 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T9 709-714 DiseaseOrPhenotypicFeature denotes tumor D009369
T10 1104-1110 DiseaseOrPhenotypicFeature denotes cancer D009369
T11 1215-1227 DiseaseOrPhenotypicFeature denotes tumourigenic DISEASE
T12 1247-1259 DiseaseOrPhenotypicFeature denotes inflammation D007249
T13 1336-1342 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T14 1463-1466 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T15 1532-1538 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T16 1647-1650 DiseaseOrPhenotypicFeature denotes HCC DISEASE

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 484-488 OrganismTaxon denotes mice
T2 1296-1301 OrganismTaxon denotes human
T3 1419-1427 OrganismTaxon denotes patients

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 65-74 ChemicalEntity denotes sorafenib D000077157|http://purl.obolibrary.org/obo/CHEBI_50924
T3 781-789 ChemicalEntity denotes tyrosine http://purl.obolibrary.org/obo/CHEBI_18186
T4 790-801 ChemicalEntity denotes phosphatase D010744
T5 1439-1448 ChemicalEntity denotes sorafenib D000077157|http://purl.obolibrary.org/obo/CHEBI_50924

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T5 1439-1448 ChemicalEntity denotes sorafenib http://purl.obolibrary.org/obo/CHEBI_50924|D000077157
T4 790-801 ChemicalEntity denotes phosphatase D010744
T3 781-789 ChemicalEntity denotes tyrosine http://purl.obolibrary.org/obo/CHEBI_18186
T1 65-74 ChemicalEntity denotes sorafenib http://purl.obolibrary.org/obo/CHEBI_50924|D000077157
T27 1474-1482 GeneOrGeneProduct denotes gankyrin
T26 1309-1317 GeneOrGeneProduct denotes Gankyrin
T25 1269-1277 GeneOrGeneProduct denotes gankyrin
T24 1173-1178 GeneOrGeneProduct denotes EpCAM
T23 1138-1171 GeneOrGeneProduct denotes epithelial cell adhesion molecule
T22 1129-1133 GeneOrGeneProduct denotes Bmi1
T21 1053-1058 GeneOrGeneProduct denotes STAT3
T20 969-977 GeneOrGeneProduct denotes Gankyrin
T19 961-966 GeneOrGeneProduct denotes STAT3
T18 909-957 GeneOrGeneProduct denotes signal transducer and activator of transcription
T17 805-810 GeneOrGeneProduct denotes SHP-1
T16 781-801 GeneOrGeneProduct denotes tyrosine phosphatase
T15 755-780 GeneOrGeneProduct denotes domain-containing protein
T14 722-730 GeneOrGeneProduct denotes Gankyrin
T13 690-694 GeneOrGeneProduct denotes VEGF
T12 669-677 GeneOrGeneProduct denotes Gankyrin
T11 652-660 GeneOrGeneProduct denotes gankyrin
T10 644-647 GeneOrGeneProduct denotes Mx1
T9 573-581 GeneOrGeneProduct denotes gankyrin
T8 553-561 GeneOrGeneProduct denotes gankyrin
T7 545-552 GeneOrGeneProduct denotes Alb-Cre
T6 526-534 GeneOrGeneProduct denotes gankyrin
T72501 445-453 GeneOrGeneProduct denotes gankyrin
T15851 348-356 GeneOrGeneProduct denotes gankyrin
T89212 239-247 GeneOrGeneProduct denotes gankyrin
T2 17-22 GeneOrGeneProduct denotes STAT3
T74841 0-8 GeneOrGeneProduct denotes Gankyrin
T98522 1647-1650 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T88120 1532-1538 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T92949 1463-1466 DiseaseOrPhenotypicFeature denotes HCC DISEASE
T90271 1336-1342 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T20570 1247-1259 DiseaseOrPhenotypicFeature denotes inflammation D007249
T69949 1215-1227 DiseaseOrPhenotypicFeature denotes tumourigenic DISEASE
T22785 1104-1110 DiseaseOrPhenotypicFeature denotes cancer D009369
T19203 709-714 DiseaseOrPhenotypicFeature denotes tumor D009369
T69700 457-463 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T1253 285-299 DiseaseOrPhenotypicFeature denotes tumourigenesis DISEASE
T32815 264-276 DiseaseOrPhenotypicFeature denotes inflammation D007249
T48597 190-202 DiseaseOrPhenotypicFeature denotes inflammation D007249
T51567 147-151 DiseaseOrPhenotypicFeature denotes HCCs D006528
T99019 120-145 DiseaseOrPhenotypicFeature denotes hepatocellular carcinomas D006528
T69082 89-113 DiseaseOrPhenotypicFeature denotes hepatocellular carcinoma D006528
T24854 37-43 DiseaseOrPhenotypicFeature denotes tumour DISEASE
T69835 1419-1427 OrganismTaxon denotes patients
T88377 1296-1301 OrganismTaxon denotes human
T65791 484-488 OrganismTaxon denotes mice